 |
|
|
| |
IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
|
| |
| |
AASLD 2019
Prof. Young-Suk LIM
Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine
|
| |
|
|
|
|
|
